Director, Translational Medicine Expert (Neurodegeneration)

Novartis UK

Greater London

Hybrid

GBP 96,000 - 178,000

Full time

33 hours ago
Be an early applicant

Get a reply from this employer

Your resume and cover letter, tailored to exactly what they’re hiring for.

Get past ATS filters

Benefits offered by this job

Hybrid working options
Parental leave (14 weeks)
Long-term equity awards
Car allowance
Insurance plans
Retirement plans
Wellbeing resources
Global recognition programs

Job summary

Novartis UK is seeking a Director, Translational Medicine Expert (Neu rodegeneration) to lead an integrated translational strategy bridging preclinical to Phase 1/2 clinical development in neurodegenerative programs. You will own biomarker strategy, clinical endpoints, and early trial design, enabling data-driven decisions and competitive positioning of neuromuscular assets.

You will co-lead early clinical development, shape dose/exposure strategies, and align TM with Clinical Development,

Qualifications

  • MD, neurologist or clinical training in neurodegenerative diseases.
  • Experience in translational medicine and early clinical development.
  • Ability to shape development strategies and influence regulatory packaging.

Responsibilities

  • Lead translational strategy across neurodegeneration programs.
  • Oversee biomarker strategy, endpoints and PK/PD considerations.
  • Co-lead early clinical development (Phase 1/2) and trial design.
  • Serve as TM representative in global project teams and cross-functional groups.
  • Drive external scientific collaborations with KOLs and academia.
  • Ensure patient-centered development and meaningful endpoints.

Skills

Translational medicine
Early clinical development
Strategic leadership

Education

MD, Neurology
PhD or PharmD desirable

Job description

Summary

Internal job title: Director
Location: London, UK
The Director, Translational Medicine Expert (Neurodegeneration) will lead the end to end translational strategy for neurodegenerative programs, bridging preclinical research to early clinical development (Phase 1–2).
This role is accountable for biomarker strategy, clinical endpoint selection, and early phase trial design, enabling efficient, data driven decision-making through key development milestones (e.g., Transition Decision Points) and ensuring competitive differentiation of neuromuscular assets.
In addition, he/she oversees the planning, execution, and interpretation of clinical trials research, data collection activities and clinical operations. Establishes and approves scientific methods for design and implementation of clinical protocols, data collection systems and final reports. Support new and ongoing clinical research and clinical trials and ensure efficient and timely processing of confidentiality agreements and clinical agreements

About The Role
Key Responsibilities
  • Translational Strategy & Program Leadership
    • Define and execute integrated translational strategies across neurodegeneration programs
    • Lead translational components from preclinical → Phase 1/2 clinical studies
    • Drive program progression through key decision gates (e.g., IND, TDP, IDPA)
    • Ensure strong mechanistic linkage between target biology, biomarkers, and clinical endpoints
  • Biomarker & Endpoint Leadership
    • Collaborate with Biomarker Development colleagues toward development and validation of:
      • Molecular biomarkers (tissue, blood, CSF where applicable)
      • Functional endpoints (strength, mobility, disease-specific measures)
      • Patient-reported outcomes (PROs)
      • Establishing quantitative biomarkers to support:
        • Target engagement
        • Disease modification
        • Dose selection and PoC decisions
    • Integrate biomarker strategy into clinical protocols and operational plans
    • Drive early biomarker de‑risking, a key priority in neuromuscular programs
  • Early Clinical Development (Phase 1/2)
    • Co‑lead design and execution of early clinical studies
    • Define:
      • Dose escalation strategy
      • Exposure–response framework
      • Translational endpoints (biopsy, imaging, functional)
    • Ensure TM leadership within Clinical Trial Teams (CTTs) for:
      • Trial design
      • Execution oversight
      • Data interpretation and decision-making
  • Cross-Functional Leadership
    • Serve as core Translational Medicine representative within global project teams
    • Partner closely with:
      • Clinical Development
      • Biomarker Development
      • Clinical Pharmacology (PKS)
      • Preclinical Safety (PCS)
      • Regulatory
    • Drive alignment between research, TM, and development organizations
  • External Scientific Leadership
    • Build and lead collaborations with:
      • Academic KOLs
      • Patient advocacy groups (critical in rare neuromuscular disease)
      • Technology partners (imaging, omics platforms)
    • Contribute to scientific strategy and external positioning of programs
  • Patient-Centered Development
    • Integrate the patient voice into translational and clinical strategies
    • Advance:
      • Meaningful functional endpoints
      • Patient-relevant outcome measures
      • Innovative trial approaches (e.g., decentralized models where feasible)
  • Portfolio Contribution & Strategic Input
    • Contribute to:
      • Asset prioritization and portfolio strategy
      • Competitive differentiation strategy (e.g., vs RNA or gene therapy competitors)
    • Provide scientific input to:
      • Business development / due diligence
      • Indication expansion strategies
    Essential Requirements
    • MD, neurologists, clinical training in neurodegenerative diseases
    • Experience in translational medicine, early clinical development, or experimental therapeutics.
    • Ability to shape development strategies, execute early clinical studies, and influence regulatory/packages supporting differentiation.
    Desirable Requirements
    • Experience working in pharmaceutical/biotech company strongly preferred.
    • PhD, PharmD, or equivalent in:
    • Neurology / Neuroscience
    • Neurodegenerative diseases
    Benefits & Rewards

    At Novartis, we’re committed to reimagining medicine together - and rewarding the people who make it happen.
    Expected Annual Base Salary Range for role: £96,036.50 - £178,353.50 GBP
    The base salary offered is determined based on gender-neutral objectives, such as relevant skills, competencies and experience in accordance with the Novartis pay setting policy and upon joining Novartis will be reviewed periodically.
    In addition to your base salary, you may be eligible for a performance-based bonus depending on certain performance parameters.
    The rewards of being part of our team go far beyond base pay and incentives. We also offer a variety of competitive benefits in kind to help you thrive personally and professionally, such as insurance plans, retirement plans, wellbeing resources and global recognition programs. In addition, we provide flexible and hybrid working options, where possible, and minimum 14 weeks paid parental leave.
    In addition to your base salary, you may be eligible for a performance-based bonus depending on certain performance parameters. Long-term equity awards granted at group level may also be part of your package. Further details will be provided during the application process.
    You may be eligible for a company vehicle or a car allowance in accordance with the applicable local Novartis policies and guidelines.
    Pay equity is a fundamental principle of our employment policy and reflects our commitment to create a diverse, equitable and inclusive environment that treats all employees with dignity and respect, as outlined in our Code of Ethics.
    Read our brochure to learn more about our global total rewards offering:
    https://www.novartis.com/sites/novartis_com/files/novartis-life-handbook.pdf
    Note: Benefits and compensation may vary by country and are subject to local legal requirements, including provisions of collective bargaining agreements where applicable. A full overview of your compensation package, including any relevant collective bargaining agreement details applicable to your role based on your employment location and Novartis employer entity, will be communicated separately to you during the application process.

    Commitment to Diversity and Inclusion / EEO

    Novartis is committed to building an outstanding, inclusive work environment and diverse teams’ representative of the patients and communities we serve.

    Why Novartis

    Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each other. Combining to achieve breakthroughs that change patients’ lives. Ready to create a brighter future together? https://www.novartis.com/about/strategy/people-and-culture

    Benefits and Rewards

    Learn about all the ways we’ll help you thrive personally and professionally.

    Read our handbook (PDF 30 MB)

    Get your free, confidential resume review.

    or drag and drop your file here.

    Similar jobs

    Similar jobs worth comparing

    Director, Translational Medicine Expert (Neurodegeneration)
    Director, Translational Medicine Expert (Neurodegeneration)

    GB16 (FCRS = GB016) Novartis Pharmaceuticals UK Ltd. • Greater London

    Hybrid
    GBP 96,000 - 178,000
    Hybrid working options
    14 weeks parental leave
    Long-term equity awards
    +1
    Director, Translational Medicine Expert (Neurodegeneration)
    Director, Translational Medicine Expert (Neurodegeneration)

    Novartis AG • Greater London

    Hybrid
    GBP 96,000 - 178,000
    Hybrid working options
    Parental leave
    Equity awards
    Director, Translational Medicine Expert (Neurodegeneration)
    Director, Translational Medicine Expert (Neurodegeneration)

    Novartis • City Of London

    Hybrid
    GBP 96,000 - 178,000
    Hybrid working
    Performance-based bonus
    Company car allowance
    +1
    Director, Translational Medicine Expert (Neurodegeneration)
    Director, Translational Medicine Expert (Neurodegeneration)

    Novartis • Greater London

    Hybrid
    GBP 96,000 - 178,000
    Insurance plans
    Retirement plans
    Wellbeing resources
    +2
    Translational Medicine Expert – Gastroenterology, Associate Director
    Translational Medicine Expert – Gastroenterology, Associate Director

    Novartis UK • Greater London

    Hybrid
    GBP 68,000 - 126,000
    Insurance plans
    Retirement plans
    Wellbeing resources
    +3
    Legal Counsel, International Strategy and Commercial Business
    Legal Counsel, International Strategy and Commercial Business

    Novartis UK • Greater London

    On-site
    GBP 82,000 - 153,000
    25 days annual leave
    Hybrid working options
    Health insurance
    +1
    Head Clinical Development AI & Technology
    Head Clinical Development AI & Technology

    Novartis • City Of London

    Hybrid
    GBP 118,000 - 219,000
    Hybrid working options
    Parental leave 14 weeks
    Insurance and retirement plans
    Senior Clinical Pharmacology Trial Leader
    Senior Clinical Pharmacology Trial Leader

    GB16 (FCRS = GB016) Novartis Pharmaceuticals UK Ltd. • Greater London

    Hybrid
    GBP 49,000 - 91,000
    Hybrid working
    Bonus potential
    Insurance plans
    +1
    Senior Director, Portfolio Scientific Communications
    Senior Director, Portfolio Scientific Communications

    Novartis • London Borough of Hammersmith and Fulham

    Hybrid
    GBP 94,000 - 174,000
    Insurance plans
    Retirement plans
    Wellbeing resources
    +2
    Senior Director, Portfolio Scientific Communications
    Senior Director, Portfolio Scientific Communications

    GB16 (FCRS = GB016) Novartis Pharmaceuticals UK Ltd. • London Borough of Hammersmith and Fulham

    Hybrid
    GBP 94,000 - 174,000
    Hybrid working options
    Parental leave (14 weeks)
    Equity awards potential